Click on the links below to read up on the latest research updates on Batten disease!

CLN1

Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep

Collaborations Pharmaceuticals, Inc. and collaborators announce publication on the efficacy of a treatment for CLN1

CLN2

A Novel Porcine Model of CLN2 Batten Disease that Recapitulates Patient Phenotypes

CLN3

CLN3 is required for the clearance of glycerophosphodiesters from lysosomes

  • Read more about this research with this article by (click the link below to read):